Pulmonary administration of erythropoietin

Details Pulmonary administration of erythropoietin Pulmonary administration of erythropoietin

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01)

Patent

CA 2155334

Erythropoietin (EPO) can be delivered systemically in therapeutically or prophylactically effective amounts by pulmonary administration using a variety of pulmonary delivery devices, including nebulizers, metered dose inhalers and powder inhalers. Aerosol administration of EPO in accordance with this invention results in significant elevation of red blood cell levels. EPO can be administered in this manner to medically treat or prevent anemia, as well as to treat or prevent other maladies related to erythropoiesis.

Affiliated with

Also associated with

Rating

Pulmonary administration of erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pulmonary administration of erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pulmonary administration of erythropoietin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1471784